Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20430 | 399 | 41.6 | 93% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3013 | 2063 | NM23//NUCLEOSIDE DIPHOSPHATE KINASE//ING4 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ING4 | Author keyword | 118 | 95% | 10% | 39 |
2 | ING1 | Author keyword | 113 | 91% | 12% | 48 |
3 | P33ING1 | Author keyword | 42 | 94% | 4% | 15 |
4 | P33ING1B | Author keyword | 38 | 93% | 4% | 14 |
5 | ING2 | Author keyword | 27 | 83% | 4% | 15 |
6 | INHIBITOR OF GROWTH 4 | Author keyword | 17 | 100% | 2% | 8 |
7 | ING3 | Author keyword | 15 | 82% | 2% | 9 |
8 | ING FAMILY | Author keyword | 15 | 88% | 2% | 7 |
9 | NS5ATP9 | Author keyword | 14 | 100% | 2% | 7 |
10 | ING5 | Author keyword | 13 | 69% | 3% | 11 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ING4 | 118 | 95% | 10% | 39 | Search ING4 | Search ING4 |
2 | ING1 | 113 | 91% | 12% | 48 | Search ING1 | Search ING1 |
3 | P33ING1 | 42 | 94% | 4% | 15 | Search P33ING1 | Search P33ING1 |
4 | P33ING1B | 38 | 93% | 4% | 14 | Search P33ING1B | Search P33ING1B |
5 | ING2 | 27 | 83% | 4% | 15 | Search ING2 | Search ING2 |
6 | INHIBITOR OF GROWTH 4 | 17 | 100% | 2% | 8 | Search INHIBITOR+OF+GROWTH+4 | Search INHIBITOR+OF+GROWTH+4 |
7 | ING3 | 15 | 82% | 2% | 9 | Search ING3 | Search ING3 |
8 | ING FAMILY | 15 | 88% | 2% | 7 | Search ING+FAMILY | Search ING+FAMILY |
9 | NS5ATP9 | 14 | 100% | 2% | 7 | Search NS5ATP9 | Search NS5ATP9 |
10 | ING5 | 13 | 69% | 3% | 11 | Search ING5 | Search ING5 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | P33ING1 | 130 | 93% | 13% | 50 |
2 | PHD FINGER PROTEINS | 56 | 100% | 5% | 19 |
3 | ING FAMILY | 42 | 94% | 4% | 15 |
4 | ING1 | 37 | 81% | 6% | 22 |
5 | ING4 | 35 | 89% | 4% | 16 |
6 | PROTEIN ING4 | 33 | 100% | 3% | 13 |
7 | PCNA ASSOCIATED FACTOR | 31 | 82% | 5% | 18 |
8 | CYCLE ALTERATION | 30 | 100% | 3% | 12 |
9 | GENE ING1 | 26 | 87% | 3% | 13 |
10 | CANDIDATE TUMOR SUPPRESSOR | 25 | 27% | 20% | 78 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The ING tumor suppressor genes: Status in human tumors | 2014 | 6 | 155 | 90% |
Keep-ING balance: Tumor suppression by epigenetic regulation | 2014 | 5 | 205 | 70% |
The new tumor suppressor genes ING: Genomic structure and status in cancer | 2008 | 50 | 57 | 98% |
The ING Gene Family in the Regulation of Cell Growth and Tumorigenesis | 2009 | 50 | 133 | 75% |
ING1 and ING2: multifaceted tumor suppressor genes | 2013 | 12 | 127 | 72% |
Different HATS of the ING1 gene family | 2002 | 121 | 55 | 75% |
Reviewing the current classification of inhibitor of growth family proteins | 2009 | 25 | 73 | 84% |
After a decade of study-ING, a PHD for a versatile family of proteins | 2007 | 70 | 83 | 64% |
Function of the ING family of PHD proteins in cancer | 2005 | 68 | 50 | 72% |
Regulation of p53 by ING family members in suppression of tumor initiation and progression | 2012 | 10 | 164 | 62% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOCHEM MOL BIOL ONCOL | 2 | 67% | 0.5% | 2 |
2 | SO ALBERTA CANC | 2 | 12% | 4.0% | 16 |
3 | FUNCT TISSUE IMAGING UNIT | 1 | 23% | 0.8% | 3 |
4 | FENXIAN HOSP | 1 | 50% | 0.3% | 1 |
5 | HAS SE LENDULET HEREDITARY ENDOCRINE TUMORS G | 1 | 50% | 0.3% | 1 |
6 | HEPATOBILIATY PANCREAT SURG | 1 | 50% | 0.3% | 1 |
7 | HUNAN ENGN BIONANOTECHNOL | 1 | 50% | 0.3% | 1 |
8 | MOL CELLULAR DEV PROGRAM | 1 | 50% | 0.3% | 1 |
9 | HEMATOL ONCOLCEDARS SINAI | 0 | 33% | 0.3% | 1 |
10 | IDIPAZ INVEST SANITARIA LA PAZ | 0 | 33% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000158859 | BRMS1//BREAST CANCER METASTASIS SUPPRESSOR 1//FDN CANC METASTASIS |
2 | 0.0000125085 | MYST//MOZ//HISTONE ACETYLTRANSFERASE |
3 | 0.0000073844 | HISTONE DEMETHYLASE//HISTONE DEMETHYLATION//LSD1 |
4 | 0.0000067844 | WWP1//SMURF1//CKIP 1 |
5 | 0.0000065139 | SEX DISCRIMINATION OF CANCER RISK//STEROID CARCINOGENESIS//TUMOR SUPPRESSOR GENE INACTIVATION |
6 | 0.0000047153 | UHRF1//ICBP90//UHRF2 |
7 | 0.0000038743 | IGFBP7//IGFBP 7//MAC30 |
8 | 0.0000036686 | SWI SNF//BRG1//ISWI |
9 | 0.0000032990 | CELLULAR SENESCENCE//SENESCENCE//BLSC |
10 | 0.0000029136 | PIKFYVE//PTDINS5P//GOLPH3 |